3 unstoppable ASX shares that keep growing

These businesses have a lot going for them.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Pro Medicus, TechnologyOne, and WiseTech are standout ASX shares known for consistent profit growth due to strong business models and customer loyalty.
  • Pro Medicus leverages high-profit margins and long-term client contracts, achieving 31.9% revenue growth and 39.2% net profit growth in FY25.
  • TechnologyOne and WiseTech maintain robust growth through strategic improvements and acquisitions, evidenced by significant revenue and profit increases, with ambitious future targets set for continued expansion.

There are plenty of ASX shares that are exposed to cyclical earnings like banks, miners, and retailers. But a select few seem capable of producing net profit growth year after year.

Long-term shareholders have already made dramatic gains with the names below, driven by enormous capital growth, thanks to an incredible rise in earnings.

Of course, past performance is not a guarantee of ongoing success. But, at the same time, great businesses have a habit of continuing to grow earnings over time.

A young boy flexes his big strong muscles at the beach.

Image source: Getty Images

Pro Medicus Ltd (ASX: PME)

Pro Medicus provides a full range of medical imaging software and services to hospitals, imaging centres, and healthcare groups. It offers an end-to-end offering, which is attractive for clients wanting just one provider. The ASX share has offices in Melbourne, Berlin, and San Diego.

The ASX share has won a wide range of clients on long-term contracts, with renewed contracts typically experiencing a higher rate, which is a strong tailwind for earnings growth.

The company has extremely high profit margins, so new revenue adds significantly to the bottom line. It's continually adding to revenue and is expected to do so for the foreseeable future.

In FY25 alone, the business achieved 31.9% revenue growth to $213 million and a 39.2% increase in net profit to $115.2 million.

TechnologyOne Ltd (ASX: TNE)

TechnologyOne is a technology business that provides enterprise resource planning (ERP) software, which is essential for the operations of clients like leading businesses, government agencies, local councils, and universities.

Almost all of the company's clients stay with the business each year – the loyalty is a great sign of how much the subscribers like it. Additionally, TechnologyOne invests heavily in its software to continually improve it for subscribers, unlocking further revenue growth opportunities.

The ASX share targets a 15% annual revenue increase each year from existing clients, while winning new subscribers is a bonus.

The business is aiming to reach $1 billion of annual recurring revenue (ARR) by FY30. It says its revenue streams come from multiple regions, multiple products, and multiple vertical markets, ensuring it can "maintain strong consistent growth".

It's also aiming to reach a (continuing operations) profit before tax (PBT) margin of at least 35% in the long term.

That combination of rising revenue and climbing profit margins should lead to a strengthening bottom line. In HY25, revenue grew by 19% and profit after tax climbed 31%.

WiseTech Global Ltd (ASX: WTC)

This company provides software to the logistics execution industry globally. Its customers include 17,000 of the world's logistics companies across 193 countries, including many of the largest logistics companies.

There is a strong drive across the world to become more efficient, so software like WiseTech can be a very valuable tool. Additionally, the world is a complex web for logistics these days, so WiseTech is helpful with that too.

Through a combination of acquisitions and organic growth, the ASX share has delivered very strong long-term growth.

In FY25 alone, revenue rose 14% and underlying net profit jumped 30% to $241.8 million. In FY26, it expects to grow revenue by between 79% to 85%, partly thanks to the acquisition of e2open.

Motley Fool contributor Tristan Harrison has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Technology One and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended Pro Medicus and Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

a man wearing casual clothes fans a selection of Australian banknotes over his chin with an excited, widemouthed expression on his face.
Growth Shares

3 ASX shares that could double over the next decade (or much sooner)

These shares could be positioned to deliver strong returns in the future. Let's find out why.

Read more »

A golden egg with dividend cash flying out of it
Growth Shares

Forget Easter eggs, these ASX shares could be your best buys this month

These shares could be top buys after the Easter break.

Read more »

Two smiling work colleagues discuss an investment at their office.
Growth Shares

3 amazing ASX growth shares I'd buy and hold for the next decade

These shares could be worth holding tightly to for the long term.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Growth Shares

$5,000 invested in Droneshield shares 4 months ago is already worth…

Investors will be thrilled!

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Dividend Investing

1 ASX dividend share and 1 ASX growth stock to buy in April

These ASX shares deliver a one-two punch: income now, growth later.

Read more »

Increasing white bar graph with a rising arrow on an orange background.
Growth Shares

Here's what I consider to be the very best ASX 200 share to buy in April

This business looks heavily undervalued to me.

Read more »

Scared people on a rollercoaster holding on for dear life, indicating a plummeting share price
Growth Shares

3 reasons to buy this red-hot ASX healthcare stock today

Brokers think the biotech share is gearing up for its next big move.

Read more »

Multi-ethnic people looking at a camera in a public place and screaming, shouting, and feeling overjoyed.
Growth Shares

2 ASX stocks that could help turn $10,000 into $1 million

I’d think about adding these ASX shares to your portfolio.

Read more »